| Date | Time | Source | Headline | Symbol | Company |
| 01/15/2009 | 1:52PM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW | NYSE:FRX | Forest Road Acquisition Corp |
| 01/15/2009 | 10:50AM | PR Newswire (US) | Seven Summits Research Releases Comments on VZ, UN, FRX, CVH, and ZION | NYSE:FRX | Forest Road Acquisition Corp |
| 01/14/2009 | 7:24PM | PR Newswire (US) | Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
| 01/14/2009 | 7:24PM | PR Newswire (US) | Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
| 01/05/2009 | 5:00PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 12/22/2008 | 8:00AM | PR Newswire (US) | Pierre Fabre Medicament and Forest Laboratories to Collaborate on Development and Commercialization of F2695 for Depression | NYSE:FRX | Forest Road Acquisition Corp |
| 12/17/2008 | 9:17AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/17/2008 | 9:03AM | PR Newswire (US) | Forest Laboratories Announces Executive Exercised Stock Options With Intent to Hold Shares | NYSE:FRX | Forest Road Acquisition Corp |
| 12/11/2008 | 2:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/10/2008 | 5:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/09/2008 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
| 12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
| 12/03/2008 | 5:04PM | PR Newswire (US) | Forest Laboratories Responds To Unsolicited Mini-Tender Offer | NYSE:FRX | Forest Road Acquisition Corp |
| 11/24/2008 | 5:00PM | PR Newswire (US) | USPTO Confirms Validity of Bystolic(R) Patent | NYSE:FRX | Forest Road Acquisition Corp |
| 11/10/2008 | 4:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 10/27/2008 | 8:00AM | PR Newswire (US) | Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infecti | NYSE:FRX | Forest Road Acquisition Corp |
| 10/23/2008 | 8:00AM | PR Newswire (US) | Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes | NYSE:FRX | Forest Road Acquisition Corp |
| 10/21/2008 | 2:30PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 10/21/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/20/2008 | 8:00AM | PR Newswire (US) | FDA Defers Final Action on milnacipran New Drug Application | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2008 | 10:20AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: ECL, ADM, NI, EGN, AMED, FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 10/07/2008 | 8:00AM | PR Newswire (US) | Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Const | NYSE:FRX | Forest Road Acquisition Corp |